Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • westerman
    Rick Westerman
    • Jun 2008
    • 1104

    #1

    Poor v.3 run

    We have done our first v.3 run and the data, while more voluminous (330M beads at 50bp mate-pair vs. 180M beads at 25bp mate-pair), seems to be of worse quality in that we are (a) not achieving as good of a coverage to the reference and (b) the number of reads with errors versus the reference is much higher.

    We were fortunate in that the customer who just completed the v.2 mate pair run wanted to redo it using v.3. So I have a good baseline for how our non-model-organism eukaryotic DNA should match up to the reference. For v.2 the coverage ranged from 69% to 87% (depending on the chromosome) while the v.3 data achieved only 56% to 73%. Obviously with about 4 times the data (~2x the beads and 2x the read length) we were expected better coverage with v.3 or at least equal coverage but certainly not worse!

    Also the number of beads with errors is much higher than with v.2.

    This is our very first v.3 run and, of course, we expect teething problems. I am ready to toss this problem off as being a startup bug. Still, if anyone has some insight into what might be causing the problem then please get hold of me. ([email protected]). Thanks.
  • nilshomer
    Nils Homer
    • Nov 2008
    • 1283

    #2
    Originally posted by westerman View Post
    We have done our first v.3 run and the data, while more voluminous (330M beads at 50bp mate-pair vs. 180M beads at 25bp mate-pair), seems to be of worse quality in that we are (a) not achieving as good of a coverage to the reference and (b) the number of reads with errors versus the reference is much higher.

    We were fortunate in that the customer who just completed the v.2 mate pair run wanted to redo it using v.3. So I have a good baseline for how our non-model-organism eukaryotic DNA should match up to the reference. For v.2 the coverage ranged from 69% to 87% (depending on the chromosome) while the v.3 data achieved only 56% to 73%. Obviously with about 4 times the data (~2x the beads and 2x the read length) we were expected better coverage with v.3 or at least equal coverage but certainly not worse!

    Also the number of beads with errors is much higher than with v.2.

    This is our very first v.3 run and, of course, we expect teething problems. I am ready to toss this problem off as being a startup bug. Still, if anyone has some insight into what might be causing the problem then please get hold of me. ([email protected]). Thanks.
    Have you checked for primer/adapter sequence. This could be more of a problem on the v3 machines though it would not explain the worse performance.

    Comment

    • westerman
      Rick Westerman
      • Jun 2008
      • 1104

      #3
      Have you checked for primer/adapter sequence. This could be more of a problem on the v3 machines though it would not explain the worse performance.
      Yes we did check for adapter read-through. There is some but it appears to be less than 1% of the beads and thus we do not see that causing our problems.

      Comment

      • cmm8cmm8
        Junior Member
        • Nov 2008
        • 9

        #4
        Did you perform a WFA on the beads? How did the titration metrics look? Also, how many beads were you getting from each emulsion after 3' end modification? Finally, how much genomic DNA did you start with for the library prep for V3 and for your V2 runs?

        Comment

        • Northeaster
          Junior Member
          • Oct 2008
          • 3

          #5
          Hi Westerman,
          I am new to v3. Did v3 mate-pair mean the 2x50bp mate-pair and the v2 mate-pair mean EcoP 2x25? Did these two libraries amplified with similar cycles? What percentage of your v3 reads are mappable? I am practicing with E. coli now. It looked good so far.

          Comment

          • westerman
            Rick Westerman
            • Jun 2008
            • 1104

            #6
            Northeaster: Yes, v.3 was 2x50bp and v.2 was 2x25bp. I didn't do the amplification but I was told that v.3 was amplified "slightly less". Percentage unique matching for v.3 was 33%. For v.2 it was 37%. But these numbers really will not be applicable to your case since I am working with an eukaryotic organism to a distantly related reference.

            cmm8cmm8: I am still trying to find out from the lab people the answers to your questions.

            Comment

            • snetmcom
              Senior Member
              • Oct 2008
              • 159

              #7
              You really do need to look at the quality of the beads you put on the slide and the deposition. If the bead counting was fine with no panel failures, then you may want to look at the N2S plots. if cycle 1 has greater than 20% N2S , then you can assume the lab made low quality beads. the WFA would tell you all of this before you ran a full slide.

              Comment

              • westerman
                Rick Westerman
                • Jun 2008
                • 1104

                #8
                The WFA run looked fine.

                It has been a while since I have posted to this thread. We have been talking with ABI/Lifetech about our run. I believe that the final conclusion is that the run itself was good but that the number of starting points is much less than it should have been. Thus we have a very high coverage on a small sub-set of the genome. How this happened is still up to debate but there seems to be a limited number possibilities: (1) the new version 3 protocol does not work well on our type of genomes or (2) our PCR reactions selected for a limited amount of the initial sequence (2) the lab techs made a mistake. #1 seems unlikely. #2 we are trying to test for. #3 is being denied by the poor lab techs who seem to get all of our abuse in the first place.

                Comment

                • snetmcom
                  Senior Member
                  • Oct 2008
                  • 159

                  #9
                  there is nothing in the v3 protocol that really changes how the system runs. You might want to look at your analysis as well. 50bp has allowed many more unique positions in our runs.

                  Comment

                  • westerman
                    Rick Westerman
                    • Jun 2008
                    • 1104

                    #10
                    snetmcom:

                    I'll disagree that there is nothing in the v.3 protocol that has changed from v.2. One really big difference is using nick translation instead of restriction enzymes for paired ends. The latter is exact while the former is a timed reaction which could be subject to a lot of vagrancies. There are other differing, albeit minor, lab steps that have changed.

                    That said, I do believe that our problem is not the protocol otherwise I do not think that ABI would have released it.

                    We have done all sorts of computational analysis. The most telling is to analyze the v.3 run as if it were a v.2 run with only 25 bases -- our restricted set of starting points also shows up in this analysis.

                    Comment

                    • pmiguel
                      Senior Member
                      • Aug 2008
                      • 2328

                      #11
                      Originally posted by westerman View Post
                      The WFA run looked fine.

                      It has been a while since I have posted to this thread. We have been talking with ABI/Lifetech about our run. I believe that the final conclusion is that the run itself was good but that the number of starting points is much less than it should have been. Thus we have a very high coverage on a small sub-set of the genome. How this happened is still up to debate but there seems to be a limited number possibilities: (1) the new version 3 protocol does not work well on our type of genomes or (2) our PCR reactions selected for a limited amount of the initial sequence (2) the lab techs made a mistake. #1 seems unlikely. #2 we are trying to test for. #3 is being denied by the poor lab techs who seem to get all of our abuse in the first place.
                      After much hand-wringing, the problem was likely caused by a choice I made and then forgot. The DNA sheared into a smaller size range than expected. But we had so much, I thought it would be fine just to extract a slice representing maybe the top 10% of the smear that was in the correct size range. None of the subsequent lab QC showed any problems.

                      I now think there is some relationship between the size that DNA fragments to and the sequence composition of that DNA. That is, while the break points introduced by shearing may be fairly random, any given narrow slice of that smear may contain a very biased subset of the entire genome. Especially if the slice being chosen is from an extreme (tail) of the distribution.

                      --
                      Phillip

                      Comment

                      Latest Articles

                      Collapse

                      • SEQadmin2
                        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
                        by SEQadmin2



                        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

                        Despite this, “CRISPR helped turn genome editing from a specialized technique into
                        ...
                        07-31-2026, 11:01 AM
                      • SEQadmin2
                        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                        by SEQadmin2


                        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                        The systematic characterization of the human proteome has
                        ...
                        07-20-2026, 11:48 AM
                      • SEQadmin2
                        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                        by SEQadmin2



                        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                        ...
                        07-09-2026, 11:10 AM

                      ad_right_rmr

                      Collapse

                      News

                      Collapse

                      Topics Statistics Last Post
                      Started by SEQadmin2, Yesterday, 07:41 AM
                      0 responses
                      12 views
                      0 reactions
                      Last Post SEQadmin2  
                      Started by SEQadmin2, 08-03-2026, 10:13 AM
                      0 responses
                      25 views
                      0 reactions
                      Last Post SEQadmin2  
                      Started by SEQadmin2, 07-31-2026, 02:55 AM
                      0 responses
                      39 views
                      0 reactions
                      Last Post SEQadmin2  
                      Started by SEQadmin2, 07-24-2026, 12:17 PM
                      0 responses
                      25 views
                      0 reactions
                      Last Post SEQadmin2  
                      Working...